You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 21, 2024

Osmotica Pharm Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for OSMOTICA PHARM, and what generic and branded alternatives to OSMOTICA PHARM drugs are available?

OSMOTICA PHARM has nine approved drugs.



Summary for Osmotica Pharm
US Patents:0
Tradenames:9
Ingredients:8
NDAs:9

Drugs and US Patents for Osmotica Pharm

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Osmotica Pharm Us RELEXXII methylphenidate hydrochloride TABLET, EXTENDED RELEASE;ORAL 216117-005 Jun 23, 2022 RX Yes No ⤷  Try a Trial ⤷  Try a Trial
Osmotica Pharm Us METHYLPHENIDATE HYDROCHLORIDE methylphenidate hydrochloride TABLET, EXTENDED RELEASE;ORAL 205327-005 Jul 28, 2017 AB RX No Yes ⤷  Try a Trial ⤷  Try a Trial
Osmotica Pharm Us HYDROMORPHONE HYDROCHLORIDE hydromorphone hydrochloride TABLET, EXTENDED RELEASE;ORAL 205629-001 Jul 7, 2016 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Osmotica Pharm Us OXYBUTYNIN CHLORIDE oxybutynin chloride TABLET, EXTENDED RELEASE;ORAL 078503-003 Feb 4, 2009 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Osmotica Pharm Us HYDROMORPHONE HYDROCHLORIDE hydromorphone hydrochloride TABLET, EXTENDED RELEASE;ORAL 205629-003 Jul 7, 2016 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Osmotica Pharm Us METHYLPHENIDATE HYDROCHLORIDE methylphenidate hydrochloride TABLET, EXTENDED RELEASE;ORAL 205327-004 Jul 28, 2017 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Osmotica Pharm Us HYDROMORPHONE HYDROCHLORIDE hydromorphone hydrochloride TABLET, EXTENDED RELEASE;ORAL 205629-004 Jul 7, 2016 AB RX No Yes ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Osmotica Pharm

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Osmotica Pharm Us VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride TABLET, EXTENDED RELEASE;ORAL 022104-002 May 20, 2008 6,403,120 ⤷  Try a Trial
Osmotica Pharm Us VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride TABLET, EXTENDED RELEASE;ORAL 022104-002 May 20, 2008 6,419,958 ⤷  Try a Trial
Osmotica Pharm Us VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride TABLET, EXTENDED RELEASE;ORAL 022104-003 May 20, 2008 6,403,120 ⤷  Try a Trial
Osmotica Pharm Us VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride TABLET, EXTENDED RELEASE;ORAL 022104-001 May 20, 2008 6,403,120 ⤷  Try a Trial
Osmotica Pharm Us VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride TABLET, EXTENDED RELEASE;ORAL 022104-003 May 20, 2008 6,419,958 ⤷  Try a Trial
Osmotica Pharm Us VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride TABLET, EXTENDED RELEASE;ORAL 022104-004 May 20, 2008 6,403,120 ⤷  Try a Trial
Osmotica Pharm Us VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride TABLET, EXTENDED RELEASE;ORAL 022104-004 May 20, 2008 6,419,958 ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.